The promise and potential pitfalls of serum biomarkers for ischemic stroke and transient ischemic attack

MLA

Aitziber Aleu, et al. “The Promise and Potential Pitfalls of Serum Biomarkers for Ischemic Stroke and Transient Ischemic Attack.” The Neurologist, vol. 14, no. 4, July 2008. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....47d9e9a3a283ddb7b3794304fedfcf0b&authtype=sso&custid=ns315887.

APA

Aitziber Aleu, Matthew B. Jensen, Justin A. Sattin, Marcus Chacon, & Patrick D. Lyden. (2008). The promise and potential pitfalls of serum biomarkers for ischemic stroke and transient ischemic attack. The Neurologist, 14(4).

Chicago

Aitziber Aleu, Matthew B. Jensen, Justin A. Sattin, Marcus Chacon, and Patrick D. Lyden. 2008. “The Promise and Potential Pitfalls of Serum Biomarkers for Ischemic Stroke and Transient Ischemic Attack.” The Neurologist 14 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....47d9e9a3a283ddb7b3794304fedfcf0b&authtype=sso&custid=ns315887.